Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Neoplasms 3Depression 3Anxiety Disorders 3Skin Neoplasms 2Urinary Bladder Neoplasms 1Keratosis, Actinic 1Hand-Foot Skin Reaction (HFSR) 1Glioblastoma 1Breast Neoplasms 1Advanced Cancer 1

Interventions

Music Therapy 15Cognitive Behavioral Therapy 13Therapeutics 12Surveys and Questionnaires 12Psychiatric Rehabilitation 9Methods 9Standard of Care 8Psilocybin 7Educational Status 7Mindfulness 6Hypnosis 6Early Intervention, Educational 6Mindfulness-Based Stress Reduction 5Mindfulness-Based Cognitive Therapy 5Massage 5Control Groups 5Art Therapy 5Aromatherapy 5Saline Solution 4Ketamine 4Interviews as Topic 4Imagery, Psychotherapy 4Esketamine 4Behavior Therapy 4Autogenic Training 4Acupuncture Therapy 4Yoga 3Weights and Measures 3Touch 3Therapeutic Touch 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Anxiety Disorders × Niacin × Clear all
NCT06200155 2026-04-16

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

M.D. Anderson Cancer Center

Phase 2 Recruiting
30 enrolled

Anxiety Disorders, Depression

NCT00302744 2025-03-13

Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Phase 1/2 Completed
12 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT00957359 2020-10-20

Psilocybin Cancer Anxiety Study

NYU Langone Health

Phase EARLY_PHASE1 Completed
29 enrolled 59 charts

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡